We found an almost significant difference between PFS in patients with and without the KRAS-G12C mutation after first-line chemotherapy.
← all excerpts
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations.
1
—
—
We found an almost significant difference between PFS in patients with and without the KRAS-G12C mutation after first-line chemotherapy.